London Daily

Focus on the big picture.
Monday, Feb 09, 2026

Hospital whistleblower raised alarm over doctor seen injecting himself

Hospital whistleblower raised alarm over doctor seen injecting himself

Exclusive: the Guardian can reveal details behind intervention at hospital in Matt Hancock’s constituency
A whistleblower raised the alarm over patient safety at Matt Hancock’s local hospital because of concerns about the behaviour of a doctor who had been seen injecting himself with drugs, the Guardian can reveal.

The incident had already prompted internal complaints from senior staff at West Suffolk hospital, but the whistleblower decided to take matters a step further when the same doctor was later involved in a potentially botched operation.

The whistleblower then wrote to relatives of a dead patient and urged them to ask questions about the conduct of the doctor and his background.

When they did this, the hospital launched a widely criticised “witch-hunt” in an attempt to find out the identity of the leaker.

The doctor’s drug use, which the trust has never acknowledged until now, helps explain why it demanded fingerprint and handwriting samples from staff – tactics which the NHS regulator roundly condemned in a hard-hitting report last week.

Last month Hancock ordered the trust to undergo a rapid review from which he recused himself after failing to act on doctors’ concerns about bullying.

In an anonymous letter to widower Jon Warby, the whistleblower said the self-injecting doctor was later present when medical blunders were made before the death of Warby’s 57-year-old wife, Susan, in August 2018.

The letter said: “He had injected himself with drugs before, while in charge of a patient and it was all hushed up.

“You need to ask questions about this doctor and what investigations had been [made] about him before. We think there is a big cover-up.”

Consultants at the trust had already raised the alarm that the doctor’s use of injected drugs could pose a risk to patients by impairing his judgment and coordination.

But rather than address the criticism of its handling of the problem, the trust’s management launched an extraordinary hunt to identify the whistleblower.

The Care Quality Commission said the lengths to which the hospital was going to find the whistleblower were “unprecedented and concerning” as it handed out its biggest ever rating downgrade.

It said the “questionable” tactics left doctors feeling intimidated, at loggerheads with bosses who it said were too focused on who sent the letter rather than why they had done so.

One doctor at the trust told the Guardian “more than 10 people felt really concerned” about the doctor’s behaviour after he was seen injecting himself intravenously with magnesium sulphate and another drug used as painkiller. They claimed the trust failed to properly respond to the incident and offer the doctor appropriate support and time off work.

A letter from a consultant sent to the trust’s medical director, Dr Nick Jenkins, in March 2018, confirmed there was “a great deal of concern” after the self-injecting episode was logged as a patient safety incident.

The letter, one of four formal complaints on the issue, said: “Rapid IV administration of magnesium can cause arrhythmias and hypotension and it is only given in this way in monitored patients. The self-administration of this drug intravenously whilst being on call can therefore only put patient safety at risk.”

It recommended that the doctor be given a “a period of leave whilst doubts are put to rest”.

A trust investigation into the incident found the doctor had done no harm to patients. The General Medical Council was informed but recommended no disciplinary sanctions.

Dozens of staff had accessed Warby’s hospital records, but it was those who had expressed concern about the drug-taking doctor who were asked to provide fingerprint and handwriting samples, insiders claim.

A doctor said: “Staff who were asked for their fingerprints were the doctors who had raised concerns about the drug-injecting doctor. Many colleagues raised concerns about him and his patients’ safety, that were ignored.”

The Guardian can also disclose that the trust is still trying to discipline a suspected whistleblower using handwriting samples and demands for fingerprints despite being heavily criticised for the practice by CQC and publicly stating it had stopped using it.

After the Guardian first revealed the trust’s tactics, managers delivered written apologies “for the stress and upset caused” to all staff involved and said it “no intention of pursuing fingerprint requests further”.

Despite this public display of contrition, bosses have since refused to drop disciplinary action against a doctor accused of being the mole on the basis of handwriting samples and their refusal to provide fingerprints.

The trust’s chief executive, Steve Dunn, personally assured a meeting of consultants that the management would no longer be using handwriting and fingerprints to pursue the matter.

A doctor said: “There is no contrition. The trust continued to pursue an aggressive and intimidatory campaign based on biometrics culminating in accusing an entirely blameless individual.”

A spokeswoman for the trust refused to discuss the investigation directly but pointed out that it was now subject to the rapid review, being overseen by the health minister Edward Argar. She said: “In these complex cases, an independent review with maximum transparency is the right way forward, and we are in support of this approach.”

On the self-injecting doctor she said: ““The matter was investigated in line with trust policies and discussed with the GMC. The individual no longer works at the trust, but, as part of our duty of care, support was provided to ensure they were fit and well to be at work during their time here.”

The doctor’s lawyer refused to comment.

The letter to Warby prompted Suffolk’s senior coroner to refer the drug claim to the police. Suffolk police decided not to investigate after establishing that no illegal drugs were involved.
Newsletter

Related Articles

0:00
0:00
Close
China and UK Signal Tentative Reset with Commitment to Steadier, Professionally Managed Relations
UK Confirms Imminent Increase in ETA Fee to £20 as Entry Rules Tighten
UK Signals Possible Seizure of Russia-Linked ‘Shadow Fleet’ Tanker in Escalation of Sanctions Enforcement
Epstein Scandal Piles Unprecedented Pressure on UK Prime Minister Keir Starmer’s Leadership
UK’s ‘Most Romantic Village’ Celebrates Valentine’s Day and Explores the Festival’s Rich History
The Implications of Expanding Voting Rights to Non-EU Foreign Residents in France
Ghislaine Maxwell to Testify Before US Congress on February 9
Al.com Acquired by Crypto.com Founder for $70 Million
Apple iPhone Lockdown Mode blocks FBI data access in journalist device seizure
Belgium: Man Charged with Rape After Faking Payment to Sex Worker
KPMG Urges Auditor to Relay AI Cost Savings
US and Iran to Begin Nuclear Talks in Oman
Winklevoss-Led Gemini to Slash a Quarter of Jobs and Exit European and Australian Markets
Canada Opens First Consulate in Greenland Amid Rising Geopolitical Tensions
China unveils plans for a 'Death Star' capable of launching missile strikes from space
NASA allows astronauts to take smartphones on upcoming missions to capture special moments.
Trump administration to launch TrumpRx.gov for direct drug purchases
Investigation Launched at Winter Olympics Over Ski Jumpers Injecting Hyaluronic Acid
U.S. State Department Issues Urgent Travel Warning for Citizens to Leave Iran Immediately
Wall Street Erases All Gains of 2026; Bitcoin Plummets 14% to $63,000
Epstein Case Documents Reignite Global Scrutiny of Political and Business Elites
Eighty-one-year-old man in the United States fatally shoots Uber driver after scam threat
UK Royal Family Faces Intensifying Strain as Epstein-Linked Revelations Rock the Institution
Political Censorship: French Prosecutors Raid Musk’s X Offices in Paris
AI Invented “Hot Springs” — Tourists Arrived and Were Shocked
Tech Mega-Donors Power Trump-Aligned Fundraising Surge to $429 Million Ahead of 2026 Midterms
UK Pharma Watchdog Rules Sanofi Breached Industry Code With RSV Vaccine Claims Against Pfizer
Melania Documentary Opens Modestly in UK with Mixed Global Box Office Performance
Starmer Arrives in Shanghai to Promote British Trade and Investment
Harry Styles, Anthony Joshua and Premier League Stars Among UK’s Top Taxpayers
New Epstein Files Include Images of Former Prince Andrew Kneeling Over Unidentified Woman
Starmer Urges Former Prince Andrew to Testify Before US Congress About Epstein Ties
Starmer Extends Invitation to Japan’s Prime Minister After Strategic Tokyo Talks
Skupski and Harrison Clinch Australian Open Men’s Doubles Title in Melbourne
DOJ Unveils Millions of Epstein Files, Fueling Global Scrutiny of Elite Networks
France Begins Phasing Out Zoom and Microsoft Teams to Advance Digital Sovereignty
China Lifts Sanctions on British MPs and Peers After Starmer Xi Talks in Beijing
Trump Nominates Kevin Warsh as Fed Chair to Reorient U.S. Monetary Policy Toward Pro-Growth Interest Rates
AstraZeneca Announces £11bn China Investment After Scaling Back UK Expansion Plans
Starmer and Xi Forge Warming UK-China Ties in Beijing Amid Strategic Reset
Tech Market Shifts and AI Investment Surge Drive Global Innovation and Layoffs
Markets Jolt as AI Spending, US Policy Shifts, and Global Security Moves Drive New Volatility
U.S. Signals Potential Decertification of Canadian Aircraft as Bilateral Tensions Escalate
Former South Korean First Lady Kim Keon Hee Sentenced to 20 Months for Bribery
Tesla Ends Model S and X Production and Sends $2 Billion to xAI as 2025 Revenue Declines
China Executes 11 Members of the Ming Clan in Cross-Border Scam Case Linked to Myanmar’s Lawkai
Trump Administration Officials Held Talks With Group Advocating Alberta’s Independence
Starmer Signals UK Push for a More ‘Sophisticated’ Relationship With China in Talks With Xi
Shopping Chatbots Move From Advice to Checkout as Walmart Pushes Faster Than Amazon
Starmer Seeks Economic Gains From China Visit While Navigating US Diplomatic Sensitivities
×